FDA approves new drug for late-stage melanoma

The U.S. Food and Drug Administration has approved the first melanoma drug in 13 years. The new drug, ipilimumab, which will be sold under the brand name Yervoy and manufactured by Bristol-Myers Squibb, is designed to stop the cancer cells from growing by stimulating the immune system to recognize the cancer cells as something to attack.

Is this hope? Read the full article here.